Matilde Lambiase

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.

European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.

Journal: International journal of molecular sciences

Published: August 02, 2023

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.

Journal: BMC cancer

Published: July 05, 2023

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics.

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics.

Journal: Diagnostics (Basel, Switzerland)

Published: June 09, 2022

Significance of rare variants in genes involved in the pathogenesis of Lynch syndrome.

Significance of rare variants in genes involved in the pathogenesis of Lynch syndrome.

Journal: International journal of molecular medicine

Published: December 14, 2021

MSH2 Overexpression Due to an Unclassified Variant in 3'-Untranslated Region in a Patient with Colon Cancer.

MSH2 Overexpression Due to an Unclassified Variant in 3'-Untranslated Region in a Patient with Colon Cancer.

Journal: Biomedicines

Published: May 13, 2020

Challenges in bioinformatics approaches to tumor mutation burden analysis.

Challenges in bioinformatics approaches to tumor mutation burden analysis.

Journal: Oncology letters

Published: March 19, 2020

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.

Journal: Cancers

Published: May 15, 2019

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.

Journal: Cancers

Published: February 12, 2019

The role of circulating free DNA in the management of NSCLC.

The role of circulating free DNA in the management of NSCLC.

Journal: Expert review of anticancer therapy

Published: November 22, 2018

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 27, 2017

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial.

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial.

Journal: ESMO open

Published: June 21, 2016

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

Journal: Oncotarget

Published: April 26, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026